Boston Partners Cuts Stock Holdings in Cigna Group $CI

Boston Partners lowered its stake in shares of Cigna Group (NYSE:CI) by 1.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 408,203 shares of the health services provider’s stock after selling 6,001 shares during the quarter. Boston Partners owned 0.15% of Cigna Group worth $134,767,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CI. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares in the last quarter. LPL Financial LLC lifted its position in Cigna Group by 14.1% during the first quarter. LPL Financial LLC now owns 207,026 shares of the health services provider’s stock valued at $68,111,000 after purchasing an additional 25,588 shares during the last quarter. Prosperity Consulting Group LLC purchased a new stake in Cigna Group during the first quarter valued at about $219,000. Mackenzie Financial Corp lifted its stake in Cigna Group by 1.7% during the first quarter. Mackenzie Financial Corp now owns 119,001 shares of the health services provider’s stock worth $39,151,000 after purchasing an additional 1,996 shares during the last quarter. Finally, Foundations Investment Advisors LLC raised its holdings in shares of Cigna Group by 25.7% during the 1st quarter. Foundations Investment Advisors LLC now owns 2,824 shares of the health services provider’s stock valued at $929,000 after buying an additional 578 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Trading Up 0.1%

NYSE CI opened at $278.60 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The stock has a market cap of $74.42 billion, a P/E ratio of 15.21, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The stock has a 50 day simple moving average of $285.55 and a two-hundred day simple moving average of $297.73.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter in the prior year, the company earned $7.51 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 26.64%.

Analyst Ratings Changes

CI has been the topic of several research reports. Barclays decreased their price target on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research note on Friday, October 31st. Zacks Research downgraded shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research note on Monday, November 3rd. JPMorgan Chase & Co. reduced their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 4th. Cowen reissued a “buy” rating on shares of Cigna Group in a research note on Tuesday, November 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $334.05.

Insider Activity

In related news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani acquired 4,134 shares of the stock in a transaction on Monday, November 3rd. The stock was bought at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.70% of the stock is owned by insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.